entertainment -WSS

entertainment

author：hotspot 2025-08-12 06:45:03 - browse：761

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How Medicaid coverage policies for immigrants impact new moms

leisure time

WSS

Startup Neumora takes a novel depression drug to Phase 3

Medicare to cover more brain scans for Alzheimer’s patients

Parents surprise family after baby discharged from NICU after 170 days

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

A public scorecard can help hold safety

As digital health tech proliferates, a new institute aims to cut through hype

explore

entertainment

explore

Medical leaders decry Supreme Court decision on affirmative action

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

The high cost of giving birth even with insurance

Eisai exec who led development of Alzheimer’s drug to retire

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The U.S. needs a new definition of substance use “recovery”

Cancer drug shortages should be causing more outrage

STAT Virtual Event: The State of Biosimilars: What to Watch

New air purifier tech could be key to improving indoor air quality

Biden declares emergency in flood

hotspot

Key House panel plots a new health care package

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Swim instructor mom warns parents not to buy blue swimsuits for kids

Google and Epic fight stronger regulation of AI in health care

Pandemic and All Hazards Preparedness Act needs lean update

Group opposing PBM reform sets lobbying record

focus

focus

leisure time

entertainment